Novo Nordisk (NOVOB DC) introduces Ozempic pill; available in the US Q2 2026; expects FDA decision on supplemental drug application for Ozempic tablets 25 mg for use in adults with Type 2 Diabetes by end of 2026
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#FDA#EU SESSION#US SESSION#EUROPEAN EQUITIES